Most medicines are developed and prescribed to a one-size-fits-all model. Perhaps then it is unsurprising that
most of them are only effective in 30-70% of patients. Because the technology to predict which medicines will
work for which patient is at a very early stage, prescribing usually follows a trial and error approach. Recent
advances in genetics and diagnostic technologies mean that in some cases it may now be possible to subgroup
patients (ie, to stratify them) according to which treatments will work best for them.
As part of an £11m programme in stratified medicines, with calls opening on 10 January 2011, the
Technology Strategy Board will invest:
up to £5.6m in collaborative research and development projects in the field of tumour profiling and data
capture
up to £1.5m in collaborative research and development projects that aim to develop and adopt business
models and value systems in this area Furthermore the Technology Strategy Board and Medical
Research Council (MRC) are to invest
up to £4m in collaborative research and development projects developing biomarkers in the area of
inflammation and immunology
The Technology Strategy Board are running a set of 3 information days designed to set the scene for the
upcoming collaborative research funding call, to supply interested parties with information about the aims
of the funding call and to provide the opportunity to develop potential consortia
London - 29th November - Holiday Inn Kensington Forum
97 Cromwell Road, London SW7 4DN
Edinburgh - 6th December - Edinburgh BioQuarter, The Queen's Medical
Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ
Manchester - 13th December - The Core Technology Facility, The University of
Manchester, 48 Grafton Street, Manchester M13 9XX
--------------------------------------------------------------------------------------------------------------------------------
To register for any of the meetings follow this link: http://www.partners4healthcare.com/index.asp
Follow Life Sciences networks on LinkedIn
GlobalScots, Nexxus, Interface, Centre for Health Science
Follow Life Sciences Scotland on Twitter
Carolyn McTaggart updated an event
Dr Shara Cohen posted events
Dr Shara Cohen commented on Dr Shara Cohen's event '3rd Annual Miniaturisation Event - Micro Scale Bioprocess Development'
Dr Shara Cohen commented on Dr Shara Cohen's event 'Cell suicide is not painless for the flow cytometrist: new assays to measure cell death'
Dr Shara Cohen commented on Dr Shara Cohen's event '3rd Improving Immunohistochemistry Discussion Forum'
Dr Shara Cohen is attending Adaora Okechuku's event
Dr Shara Cohen commented on Dr Shara Cohen's event '3rd Annual “Induced Pluripotent Stem Cells: Production and Utility in Regenerative Medicine"'
© 2012 Created by Siobhan McDermit.
Powered by
You need to be a member of Life Sciences Scotland to add comments!
Join Life Sciences Scotland